Market Reaction Reverses: AstraZeneca Rallies as Bristol-Myers Retreats After Merger Rumor Denied
The market quickly unwound a short-lived merger narrative after a senior source said there were "no discussions" and "never was a deal." AstraZeneca rose on relief while Bristol-Myers Squibb gave back earlier gains as the takeover premium evaporated. Investors now face the same strategic questions that prompted speculation: how will AstraZeneca gro…